Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:leukemia
gptkb:disease |
| gptkbp:affects |
gptkb:skin
lymphatic system |
| gptkbp:associatedWith |
TCR gene rearrangement
|
| gptkbp:causedBy |
gptkb:unknown
|
| gptkbp:complication |
sepsis
secondary infections systemic spread |
| gptkbp:diagnosedBy |
histopathology
skin biopsy |
| gptkbp:firstDescribed |
1806
|
| gptkbp:hasEpidemiology |
more common in men
median age at diagnosis 55-60 years |
| gptkbp:hasTreatmentGoal |
disease control
symptom relief |
| gptkbp:hasTypicalOnset |
adulthood
|
| gptkbp:histology |
Pautrier microabscesses
atypical lymphocytes epidermotropism |
| gptkbp:ICD-10_code |
C84.0
|
| gptkbp:mortalityRate |
increased in advanced stages
|
| gptkbp:namedAfter |
gptkb:Alibert
|
| gptkbp:originatedIn |
T lymphocyte
|
| gptkbp:prevalence |
rare
|
| gptkbp:prognosis |
variable
|
| gptkbp:riskFactor |
African descent
male sex older age |
| gptkbp:stageName |
erythrodermic stage
patch stage plaque stage tumor stage |
| gptkbp:symptom |
tumors
plaques itching skin rash patches enlarged lymph nodes |
| gptkbp:synonym |
Alibert-Bazin syndrome
cutaneous T-cell lymphoma, type MF |
| gptkbp:treatment |
gptkb:radiation_therapy
gptkb:immunotherapy phototherapy retinoids topical corticosteroids systemic chemotherapy |
| gptkbp:bfsParent |
gptkb:Ledaga
gptkb:brentuximab_vedotin gptkb:Sézary_syndrome |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
mycosis fungoides
|